DOI QR코드

DOI QR Code

MicroRNA-21 Regulates the Invasion and Metastasis in Cholangiocarcinoma and May Be a Potential Biomarker for Cancer Prognosis

  • Huang, Qiang (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University) ;
  • Liu, Lei (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University) ;
  • Liu, Chen-Hai (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University) ;
  • You, Hao (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University) ;
  • Shao, Feng (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University) ;
  • Xie, Fang (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University) ;
  • Lin, Xian-Sheng (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University) ;
  • Hu, San-Yuan (Department of General Surgery, Qilu Hospital of Shandong University) ;
  • Zhang, Chuan-Hai (Department of General Surgery, Affiliated Provincial Hospital of Anhui Medical University)
  • Published : 2013.02.28

Abstract

Background: MicroRNAs are noncoding RNA molecules that posttranscriptionally regulate gene expression. The aim of this study was to determine the role of microRNA-21 in cholangiocarcinomas and its relationship to cholangiocarcinoma RBE cell capacity for invasion and metastasis. Methods: MicroRNA-21 expression was investigated in 41 cases of cholangiocarcinoma samples by in situ hybridization and real-time PCR. Influence on cholangiocarcinoma cell line invasion and metastasis was analyzed with microRNA-21 transfected cells. In addition, regulation of reversion-inducing-cysteine-rich protein with kazal motifs (RECK) by microRNA-21 was elucidated to identify mechanisms. Results: In situ hybridization and real-time quantitative PCR results for patients with lymph node metastasis or perineural invasion showed significantly high expression of microRNA-21 (P<0.05). There was a dramatic decrease in cholangiocarcinoma cell line invasion and metastasis ability after microRNA-21 knockdown (P<0.05). However, overexpression significantly increased invasion and metastasis (P<0.05). Real-time PCR and Western-blot analysis showed that microRNA-21 could potentially inhibit RECK expression in RBE cells. Survival analysis showed that patients with higher expression levels of microRNA-21 more often had a poor prognosis (P<0.05). Conclusions: MicroRNA-21 may play an important role in cholangiocarcinoma invasion and metastasis, suggesting that MicroRNA-21 should be further evaluated as a biomarker for predicting cholangiocarcinoma prognosis.

Keywords

References

  1. Andersen JB, Thorgeirsson SS (2012). Genetic profiling of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol, 28, 266-72. https://doi.org/10.1097/MOG.0b013e3283523c7e
  2. Blechacz B, Gores GJ (2008). Cholangiocarcinoma:advances in pathogenesis, diagnosis, and treatment. Hepatology, 48, 308-21.
  3. Blechacz B, Komuta M, Roskams T, et al (2011). Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol, 8, 512-22. https://doi.org/10.1038/nrgastro.2011.131
  4. Chan SH,Wu CW, Li AF, et al (2008). miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res, 28, 907-11.
  5. Cioffi JA, Yue WY, Mendolia-Loffredo S, et al (2010). MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival. Otol Neurotol, 31, 1455-62.
  6. Dillhoff M, Liu J, Frankel W, et al (2008). MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg, 12, 2171-76. https://doi.org/10.1007/s11605-008-0584-x
  7. Dong CG, Wu WK, Feng SY, et al (2012). Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. Int J Oncol, 41, 1005-1112.
  8. Han L, Yue X, Zhou X, et al (2011). MicroRNA-21 is involved in osteosarcoma cell invasion and metastasis. Med Oncol, 28, 1469-74. https://doi.org/10.1007/s12032-010-9563-7
  9. Hiyoshi Y, Kamohara H, Karashima R, et al (2009). MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res, 15, 1915-22. https://doi.org/10.1158/1078-0432.CCR-08-2545
  10. Iorio MV, Croce CM (2012). MicroRNA involvement in human cancer. Carcinogenesis, 33, 1126-33. https://doi.org/10.1093/carcin/bgs140
  11. Iorio MV, Visone R, Di Leva G, et al (2007). MicroRNA signatures in human ovarian cancer. Cancer Res, 67, 8699-707. https://doi.org/10.1158/0008-5472.CAN-07-1936
  12. Li B, Han Q, Zhu Y, et al(2012). Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. FEBS J, 279, 2393-8. https://doi.org/10.1111/j.1742-4658.2012.08618.x
  13. Liu C, Yu J, Yu S, et al (2010). MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol, 53, 98-107. https://doi.org/10.1016/j.jhep.2010.02.021
  14. Liu ZL, Wang H, Liu J, et al (2012). MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo-or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem, 6, 21.
  15. Markou A,Tsaroucha EG, Kaklamanis L, et al (2008). Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem, 54, 1696-704. https://doi.org/10.1373/clinchem.2007.101741
  16. Meng F, Henson R,Wehbe-Janek H, et al(2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-58. https://doi.org/10.1053/j.gastro.2007.05.022
  17. Pillai RS (2005). MicroRNA function: multiple mechanisms for a tiny RNA? RNA, 11, 1753-61. https://doi.org/10.1261/rna.2248605
  18. Rosenfeld N, Aharonov R, Meiri E, et al (2008). MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol, 26, 462-9. https://doi.org/10.1038/nbt1392
  19. Sawanyawisuth K (2009). Genes and cholangiocareinoma.Southeast Asian J Trop Med Public Health, 40, 701-12.
  20. Schetter AJ, Leung SY, Sohn JJ, et al (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-36. https://doi.org/10.1001/jama.299.4.425
  21. Selaru FM, Olaru AV, Kan T, et al (2009). MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology, 49, 1595-601. https://doi.org/10.1002/hep.22838
  22. Sempere LF, Christensen M, Silahtaroglu A, et al(2007). Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res, 67, 11612-20. https://doi.org/10.1158/0008-5472.CAN-07-5019
  23. Shen FZ, Zhang BY, Feng YJ, et al (2010). Current research in perineural invasion of cholangiocarcinoma. J Exp Clin Cancer Res, 10, 24.
  24. Slaby O, Svoboda M, Fabian P, et al (2007). Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology, 72, 397-402. https://doi.org/10.1159/000113489
  25. Slaby O, Svoboda M, Fabian P, et al (2007). Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology, 72, 397-402. https://doi.org/10.1159/000113489
  26. Snowdon J, Zhang X, Childs T, Tron VA, Feilotter H (2011). The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One, 6, e22828. https://doi.org/10.1371/journal.pone.0022828
  27. Zhang J, Han C, Wu T (2012). MicroRNA-26a promotes cholangiocarcinoma growth by activating $\beta$-catenin. Gastroenterology, 143, 246-56. https://doi.org/10.1053/j.gastro.2012.03.045
  28. Ziyan W, Shuhua Y, Xiufang W, et al (2011). MicroRNA-21 is involved in osteosarcoma cell invasion and metastasis. Med Oncol, 8, 1469-74.

Cited by

  1. MicroRNA-451 Inhibits Growth of Human Colorectal Carcinoma Cells via Downregulation of Pi3k/Akt Pathway vol.14, pp.6, 2013, https://doi.org/10.7314/APJCP.2013.14.6.3631
  2. Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5617
  3. Detection of MicroRNA-21 Expression as a Potential Screening Biomarker for Colorectal Cancer: a Meta-analysis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7583
  4. The Real-Time Dynamic Monitoring of microRNA Function in Cholangiocarcinoma vol.9, pp.6, 2014, https://doi.org/10.1371/journal.pone.0099431
  5. Prognostic Value of miR-21 in Various Cancers: An Updating Meta-Analysis vol.9, pp.7, 2014, https://doi.org/10.1371/journal.pone.0102413
  6. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment vol.4, pp.9, 2015, https://doi.org/10.3390/jcm4091688
  7. The Clinical Utility of MicroRNA as a Prognostic Biomarker of Pancreatobiliary Cancers vol.10, pp.5, 2016, https://doi.org/10.5009/gnl16309
  8. Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma vol.11, pp.9, 2016, https://doi.org/10.1371/journal.pone.0163699
  9. miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt/ERK1/2 pathway vol.50, pp.4, 2017, https://doi.org/10.3892/ijo.2017.3876
  10. The role of miRNAs in cholangiocarcinoma vol.3, pp.2, 2016, https://doi.org/10.2217/hep-2015-0003
  11. MicroRNA-382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF-mediated PI3K/AKT signalling pathway vol.16, pp.5, 2017, https://doi.org/10.3892/mmr.2017.7396